ATI RN
ATI Pharmacology 2023 Questions
Extract:
Question 1 of 5
A nurse is preparing to administer heparin subcutaneously to a client. Which of the following actions should the nurse plan to take to minimize bleeding following the injection?
Correct Answer: B
Rationale: The correct answer is B: Grasp skin between thumb and forefinger throughout the injection. This technique helps to stabilize the tissue around the injection site, reducing the risk of bleeding. By holding the skin taut, the needle can be inserted more accurately, minimizing trauma to the blood vessels and tissues. This method also helps prevent the medication from leaking out of the injection site, ensuring proper absorption.
For the other choices:
A: Gently massaging the site following the injection can increase bleeding by disrupting the clotting process.
C: The Z-track method is used for intramuscular injections, not subcutaneous, and is not necessary to minimize bleeding in this case.
D: Aspirating the syringe is not required for subcutaneous injections and does not directly impact bleeding following the injection.
Question 2 of 5
A nurse is preparing to mix short-acting insulin with NPH insulin from two vials. Which of the following actions should the nurse take?
Correct Answer: A
Rationale:
Rationale: Option A is correct because when mixing short-acting insulin with NPH insulin, air should be injected into the NPH insulin vial first to prevent creating a vacuum. This allows for easier withdrawal of the short-acting insulin. Injecting air into the short-acting insulin vial could lead to contamination of the insulin. Option B is incorrect because insulin should be administered within 5-10 minutes of mixing, not 20. Option C is incorrect since the short-acting insulin should be drawn into the syringe first to avoid contamination. Option D is incorrect as using two separate syringes is unnecessary and increases the risk of dosing errors.
Question 3 of 5
A nurse is caring for a client who has a prescription for nifedipine. Which of the following findings should the nurse assess prior to administration of the medication?
Correct Answer: A
Rationale: The correct answer is A: Blood pressure. Nifedipine is a calcium channel blocker used to treat hypertension. Before administering, the nurse should assess the client's blood pressure as this medication can cause hypotension as a side effect. Monitoring blood pressure ensures safety and effectiveness of the medication. Assessing respiratory rate, temperature, and oxygen saturation are important but not specific to nifedipine administration. Blood pressure is the priority assessment in this case.
Question 4 of 5
A nurse is planning to administer a prefilled syringe of enoxaparin to a client. Which of the following actions should the nurse take?
Correct Answer: D
Rationale: The correct answer is D: Administer the medication into the anterolateral or posterolateral abdominal area. This site is recommended for enoxaparin injection as it minimizes the risk of hitting a large blood vessel or nerve. It also provides a safe and effective route for absorption. Massaging the injection site (
Choice
A) is not recommended as it can cause bruising or irritation. Expelling air bubbles (
Choice
B) is important to prevent air embolism, but this is not typically a concern with prefilled syringes. Holding the skin taut (
Choice
C) is not necessary and may cause unnecessary discomfort. Administering the medication into other areas of the body (
Choice E, F, G) may not provide consistent absorption or could lead to complications.
Question 5 of 5
A nurse is planning care for a group of clients. Which of the following client's medications should be monitored by the nurse for hearing loss related to a medication interaction?
Correct Answer: C
Rationale: The correct answer is C: Furosemide and amikacin. Furosemide is a loop diuretic known to cause hearing loss, especially when combined with amikacin, an aminoglycoside antibiotic also associated with ototoxicity. The interaction between these two medications can potentiate the risk of hearing loss. Propranolol, raloxifene, losartan, atorvastatin, digoxin, and levothyroxine are not typically associated with hearing loss as a medication interaction. Monitoring Furosemide and amikacin is crucial to prevent potential auditory complications.